Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease: The NICE Trial

NCT03743636 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT03743636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03743636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease: The NICE Trial
Lead sponsor
Northwestern University
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2018
Completion date
May 23, 2023
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease